Acetaminophen : properties, clinical uses, and adverse effects /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York : Nova Biomedical/Nova Science Publishers, Incorporated, [2012]
Colección:Public health in the 21st century series.
Nova biomedical.
Pharmacology-research, safety testing, and regulation series.
Temas:
Acetaminophen.
Acetaminophen
Paracétamol.
MEDICAL > Pain Medicine.
Analgesics.
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBSCO_on1162283471
003 OCoLC
005 20231017213018.0
006 m o d
007 cr |||||||||||
008 120622s2012 nyua ob 001 0 eng
010 |a  2019714237 
040 |a DLC  |b eng  |e rda  |c DLC  |d OCLCF  |d VLY  |d OCLCO  |d YDX  |d YDXCP  |d N$T  |d E7B  |d EBLCP  |d DEBSZ  |d AGLDB  |d VTS  |d STF  |d AU@  |d K6U  |d AJS  |d OCLCO  |d OCLCQ 
019 |a 828140617  |a 923652949  |a 1138136602  |a 1140692480 
020 |a 9781619423756  |q ebook 
020 |a 1619423758 
020 |z 161942374X  |q hbk. 
020 |z 9781619423749  |q hbk. 
029 1 |a AU@  |b 000051707029 
029 1 |a DEBBG  |b BV041049670 
029 1 |a DEBBG  |b BV043774727 
029 1 |a DEBSZ  |b 472770799 
035 |a (OCoLC)1162283471  |z (OCoLC)828140617  |z (OCoLC)923652949  |z (OCoLC)1138136602  |z (OCoLC)1140692480 
050 0 0 |a RM666.A19 
060 4 |a QV 95 
072 7 |a MED  |x 093000  |2 bisacsh 
082 0 4 |a 615.783 
049 |a UAMI 
245 0 0 |a Acetaminophen :  |b properties, clinical uses, and adverse effects /  |c Atash Javaherian and Pasha Latifpour, editors. 
264 1 |a New York :  |b Nova Biomedical/Nova Science Publishers, Incorporated,  |c [2012] 
300 |a 1 online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Public health in the 21st century series 
490 1 |a Nova biomedical 
490 1 |a Pharmacology--research, safety testing and regulation 
504 |a Includes bibliographical references and index. 
588 |a Description based on print version record. 
505 0 |a ""ACETAMINOPHEN ""; ""ACETAMINOPHEN ""; ""CONTENTS ""; ""PREFACE ""; ""ACETAMINOPHEN (PARACETAMOL): PROPERTIES, CLINICAL USES, AND ADVERSE EFFECTS""; ""ABSTRACT ""; ""1. INTRODUCTION ""; ""2. PROPERTIES ""; ""2.1. Chemistry ""; ""2.2. Pharmacokinetics ""; ""2.2.1. Absorption ""; ""2.2.1.1. Immediate Release ""; ""2.2.1.2. Extended Release ""; ""2.2.1.3. Intravenous ""; ""2.2.2. Distribution ""; ""2.2.2.1. Spinal Fluid""; ""2.2.2.2. Placental Barrier ""; ""2.2.2.3. Breast Milk ""; ""2.2.3. Metabolism ""; ""2.2.4. Elimination ""; ""2.2.5. Fetus, Neonates, Infants, and Children"" 
505 8 |a ""2.2.6. Geriatric """"3. CLINICAL USES ""; ""3.1. Antipyresis ""; ""3.2. Analgesia ""; ""4. SPECIAL POPULATIONS ""; ""4.1. Chronic Liver Disease ""; ""4.2. Renal Disease ""; ""4.3. Calorie Restricted Patients ""; ""4.4. HIV ""; ""4.5. Gilbertâ€?s Syndrome ""; ""5. ADVERSE EVENTS ""; ""5.1. Allergy and Hypersensitivity ""; ""5.2. Central Nervous System ""; ""5.3. Gastrointestinal ""; ""5.4. Hemotologic and Hemostatic ""; ""5.5. Hepatic Toxicity ""; ""5.6. Pregnancy and Lactation ""; ""5.7. Renal ""; ""6. DDIS ""; ""6.1. Overdose ""; ""6.1.1. NAC Treatment "" 
505 8 |a ""7. ACETAMINOPHEN FORMULATIONS """"7.1. Combinations ""; ""7.2. IV Formulation ""; ""CONCLUSION ""; ""REFERENCES ""; ""CLINICAL AND EXPERIMENTAL RELEVANCE OF HYPOTHERMIA IN ACETAMINOPHEN HEPATOTOXICITY ""; ""ABSTRACT ""; ""1. INTRODUCTION ""; ""2. APAP-INDUCED HEPATOTOXICITY IN PATIENTS WITH ALF""; ""3. APAP-INDUCED HEPATOTOXICITY IN EXPERIMENTAL MODELS""; ""3.a. Determinants of APAP-Induced Hepatotoxicity in Experimental Animal Models ""; ""3.b. Histopathology ""; ""4. MECHANISMS OF APAP-INDUCED LIVER INJURY ""; ""5. BODY TEMPERATURE, APAP AND THE LIVER "" 
505 8 |a ""5.a. Reduction of Body Temperature Due to APAP in Humans """"5.b. Reduction of Body Temperature in Experimental Animal Models of Liver Injury""; ""6. RELEVANCE OF BODY TEMPERATURE FOR APAP-INDUCED ALF ""; ""6.1. Effects of Hypothermia on the Development of Brain Edema and Intracranial Hypertension in ALF""; ""6.2. Effects of Hypothermia on the Progression of Liver Injury""; ""CONCLUSIONS ""; ""REFERENCES ""; ""NOVEL APPLICATIONS OF ACETAMINOPHEN ""; ""ABSTRACT ""; ""1.INTRODUCTION ""; ""2. CHRONIC ACETAMINOPHEN INGESTION CAN IMPROVE BLOOD GLUCOSE CONTROL "" 
505 8 |a ""3. LONG TERM ACETAMINOPHEN INGESTION CAN IMPROVE SKELETAL MUSCLE STRUCTURE AND FUNCTION""""4. ACETAMINOPHEN POSSESSES CARDIOPROTECTIVE AND NEUROPROTECTIVE PROPERTIES ""; ""5. ACETAMINOPHEN EXHIBITS POTENT ANTIOXIDANT ACTIVITY ""; ""CONCLUSIONS AND PERSPECTIVES ""; ""CONFLICT OF INTEREST STATEMENT ""; ""ACKNOWLEDGMENTS ""; ""REFERENCES ""; ""ADVANCED METHODS FOR THE REMOVAL OF ACETAMINOPHEN FROM WATER ""; ""ABSTRACT ""; ""1. INTRODUCTION ""; ""2. PHARMACEUTICALS AS EMERGENT POLLUTANTS ""; ""3. ACETAMINOPHEN IN WATER RESOURCES ""; ""4. ACETAMINOPHEN REMOVAL AND DEGRADATION "" 
546 |a English. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Acetaminophen. 
650 2 |a Acetaminophen 
650 6 |a Paracétamol. 
650 7 |a MEDICAL  |x Pain Medicine.  |2 bisacsh 
650 7 |a Acetaminophen.  |2 fast  |0 (OCoLC)fst00795571 
650 7 |a Analgesics.  |2 fast  |0 (OCoLC)fst00808271 
700 1 |a Javaherian, Atash,  |e editor of compilation. 
700 1 |a Latifpour, Pasha,  |e editor of compilation. 
776 0 8 |i Print version:  |t Acetaminophen  |d New York : Nova Biomedical/Nova Science Publishers, Inc., [2012]  |z 9781619423749 (hbk.)  |w (DLC) 2012405393 
830 0 |a Public health in the 21st century series. 
830 0 |a Nova biomedical. 
830 0 |a Pharmacology-research, safety testing, and regulation series. 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=540919  |z Texto completo 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL3017731 
938 |a ebrary  |b EBRY  |n ebr10654702 
938 |a EBSCOhost  |b EBSC  |n 540919 
938 |a YBP Library Services  |b YANK  |n 7252232 
994 |a 92  |b IZTAP 

Ejemplares similares